Skip to content

GeneDx Holdings WGS Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin69.6%-0.2pp69.7%+0.1pp69.6%+2.5pp67.2%+1.9pp65.3%+1.6pp
Efficiency
Asset turnover0.9×0.0×0.9×0.0×0.9×0.0×0.8×+0.1×0.8×+0.1×
Liquidity
Current ratio3.1×+0.6×2.5×-0.2×2.7×-0.2×2.9×-0.4×3.2×-0.4×
Leverage
Debt-to-equity0.4×0.0×0.4×+0.2×0.2×0.0×0.2×0.0×0.2×-0.3×
Per Share
Book value per share$8.66-19.5%$10.76+6.0%$10.15+9.0%$9.31+1.9%$9.14+0.3%
Valuation
Market capitalization$1.88B-50.0%$3.76B+21.5%$3.09B+19.3%$2.59B+4.3%$2.49B+17.7%
Price / sales4.2×-4.5×8.8×+1.1×7.7×+0.5×7.2×-0.4×7.5×+0.6×
Price / book7.4×-4.8×12.2×+1.6×10.6×+1.2×9.4×-0.3×9.7×+1.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do GeneDx Holdings's ratios come from?
Every ratio is computed from GeneDx Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.